Close Menu

NEW YORK – Interpace Diagnostics said today that its subsidiary Interpace BioPharma has partnered with Beijing, China-based Genecast Biotechnology to jointly develop, promote, and offer translational studies and clinical trial solutions to biotech and pharmaceutical companies.  

As part of the collaboration, Parsippany, New Jersey-based Interpace will perform services worldwide except in China, where Genecast will provide services. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.